Clinical Trial Update: Rezafungin Pharmacokinetics in Patients on ECMO [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating rezafungin pharmacokinetics in patients on ECMO has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: Hartford Hospital | Conditions: Sepsis | Phase 1 | Status: WITHDRAWN